DexCom Inc share price logo

DexCom Inc

NASDAQ: DXCM

Large Cap

$60.02

-1.33

(-2.17%)

as on

DexCom Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $59.16
    $61.63
    downward going graph

    1.43%

    Downside

    2.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $54.11
    $89.98
    downward going graph

    9.85%

    Downside

    49.92%

    Upside

    downward going graph

DexCom Inc share price movements today

Previous Close
$61.35
Open
$61.61
Volume
3.9M
Day's Low - High
$59.16 - $61.63
52 Week Low - High
$54.11 - $89.98

DexCom Inc Historical Returns

1 Month Return
-1.4 %
3 Month Return
-12.22 %
1 Year Return
-23.57 %
3 Year Return
-49.22 %
5 Year Return
-32.94 %

DexCom Inc Stock Fundamentals & Key Indicators

Check DexCom Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.7B

EPS (TTM)

2.5742

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.92%

PE Ratio (TTM)

26.33

Industry PE ratio

37.11909090909091

PEG Ratio

1.34

EBITDA

1.3B

Revenue (TTM)

4.8B

Profit Margin

19.31%

Return On Equity TTM

35.62%

DexCom Inc Stock Valuation

Track how DexCom Inc P/E has moved over time to understand its valuation trends.

DexCom Inc in the last 5 years

  • Overview

  • Trends

Lowest (29.89x)

March 31, 2026

Today (26.33x)

May 5, 2026

Industry (37.12x)

May 5, 2026

Highest (175.15x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 26.33x

DexCom Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of DexCom Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$23.7B-32.94%26.3319.31%
BUY$84.0B31.12%23.6417.29%
BUY$112.9B16.46%35.0913.21%
BUY$48.4B-8.49%45.3917.39%
BUY$102.7B-37.01%22.3513.00%

Stock Returns calculator for DexCom Inc Stock including INR - Dollar returns

The DexCom Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

DexCom Inc investment value today

Current value as on today

₹84,328

Returns

-₹15,672

(-15.67%)

Returns from DexCom Inc Stock

-₹25,227 (-25.23%)

Dollar Impact

₹9,556 (+9.56%)

Analyst Recommendation on DexCom Inc Stock

Based on 30 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for DexCom Inc. Average target price of $83.54

DexCom Inc Share Price Target

Get share price movements and forecasts by analysts on DexCom Inc.

What analysts predicted

28.15%UPSIDE

Target Price

$83.54

Current Price

$60.02

Analyzed by

30 Analysts

Target

$83.54

DexCom Inc target price $83.54, a slight upside of 28.15% compared to current price of $60.02. According to 30 analysts rating.

DexCom Inc Stock’s Investor Sentiment and Interest

Investment in DexCom Inc Shares on INDmoney has grown by 68.08% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:68.08% versus previous 30 day period

Search interest for DexCom Inc Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

DexCom Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1,034
921
1,004
994
1,113
1,036
1,157
1,209
1,259
1,191
Gross Profit
656
561
626
593
655
589
688
747
792
750
Operating Income
216
101
158
152
188
133
212
242
323
255
EBITDA
303
189
244
237
274
219
275
306
388
255
Interest Expense
4
4
4
4
4
4
4
4
4
3
Depreciation
52
52
52
55
57
60
63
63
65
67
Income Before Tax
246
132
187
177
211
154
241
352
340
269
Income Tax Expense
-10
-13
44
42
59
48
61
68
73
70
Net Income
256
146
143
134
151
105
179
283
267
199
Net Profit Margin
24.78%
15.90%
14.29%
13.54%
13.62%
10.17%
15.54%
23.47%
21.22%
16.74%

DexCom Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
573
718
1,031
1,476
1,926
2,448
2,909
3,622
4,033
4,662
Gross Profit
378
492
663
931
1,280
1,680
1,883
2,288
2,438
2,797
Operating Income
-63
-42
-186
142
299
265
391
597
600
911
EBITDA
-49
-19
-74
213
376
377
565
916
945
1,163
Interest Expense
0
12
22
60
84
18
18
20
19
18
Depreciation
-
16
29
48
67
102
155
186
217
251
Income Before Tax
-64
-48
-126
104
225
256
390
710
709
1,088
Income Tax Expense
0
1
0
3
-268
39
49
168
132
252
Net Income
-65
-50
-127
101
493
216
341
541
576
836
Net Profit Margin
-11.44%
-6.99%
-12.32%
6.85%
25.62%
8.86%
11.73%
14.95%
14.29%
17.94%

DexCom Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
146
143
134
151
105
179
283
267
199
Operating Cash Flow
209
279
199
301
183
303
659
294
525
Investing Cash Flow
74
-188
210
-303
100
-63
192
306
-298
Financing Cash Flow
4
-1
-736
-1
12
-1
-175
-1,522
-25
Change in Cash
284
88
-316
-15
298
254
676
-917
199

DexCom Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-127
101
493
154
341
541
576
836
Operating Cash Flow
92
123
314
475
442
669
748
989
1,440
Investing Cash Flow
-144
-139
-1,015
-1,018
-216
-521
-507
-207
536
Financing Cash Flow
399
710
10
912
10
-552
-318
-734
-1,686
Change in Cash
347
695
-690
371
235
-410
-75
39
311

Mutual Funds that own DexCom Inc Stock

Check out the Mutual Funds with significant holdings in DexCom Inc.

Global Institutional Holdings in DexCom Inc

Funds
Holdings
American Century Companies Inc
0.99%
AQR Capital Management LLC
0.8%
Amundi
1.27%
BlackRock Inc
10.09%
Nuveen, LLC
1.2%

DexCom Inc News & Key Events

  • img

    Today's Timeline - 13 February

    Fri, 05:31 PM

    -

    DexCom reports strong Q4 2025 results, with revenue of $1.26 billion and adjusted earnings of $0.68 per share.

    Fri, 10:01 PM

    -

    DexCom shares jump 7.3% after beating revenue and earnings estimates, despite guidance aligning with analyst expectations.

    Fri, 11:16 PM

    -

    DexCom maintains 2026 revenue guidance of $5.16 billion to $5.25 billion after strong Q4 performance.

Insights on DexCom Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DXCM stock has moved up by 3.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 11.8% return, outperforming this stock by 35.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, DexCom, Inc. has experienced a drawdown of -49.2%, however Boston Scientific Corp. resisted the overall trend and outperformed by 43.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 283.8M → 199.5M (in $), with an average decrease of 15.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.25B → 1.19B (in $), with an average decrease of 5.4% per quarter

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
OrganisationDexCom Inc
Headquarters6340 Sequence Drive, San Diego, CA, United States, 92121
IndustryMedical Devices
CEOMr. Jacob Steven Leach
E-voting on sharesClick here to vote

Key Management of DexCom Inc

Name

Title

Mr. Michael Jon Brown J.D.

Executive VP & Chief Legal Officer

Mr. Girish Naganathan

Executive VP & CTO

Mr. Matthew Dolan

Executive Vice President of Strategy & Corporate Development

Mr. Kevin Ronald Sayer

Executive Chairman of the Board

Mr. Jacob Steven Leach

President, CEO & Director

Mr. Jereme M. Sylvain CPA

Executive VP, CFO & Chief Accounting Officer

Ms. Sadie M. Stern

Executive VP & Chief Human Resources Officer

Mr. Jon Coleman

Executive VP & Chief Commercial Officer

Mr. Sean Christensen

Vice President of Finance and Investor Relations

Mr. Donald M. Abbey

Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs

FAQs

What is DexCom Inc share price today?

DexCom Inc share price today is $60.02 as on at the close of the market. DexCom Inc share today touched a day high of $61.63 and a low of $59.16.

What is the 52 week high and 52 week low for DexCom Inc share?

DexCom Inc share touched a 52 week high of $89.98 on and a 52 week low of $54.11 on . DexCom Inc stock price today i.e. is closed at $60.02,which is 33.30% down from its 52 week high and 10.92% up from its 52 week low.

What is DexCom Inc's market capitalisation today?

DexCom Inc market capitalisation is $0.02T as on .

How to invest in DexCom Inc Stock (DXCM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for DexCom Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in DexCom Inc Shares that will get you 0.0250 shares as per DexCom Inc share price of $60.02 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy DexCom Inc Stock (DXCM) from India?

Indian investors can start investing in DexCom Inc (DXCM) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in DexCom Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on DexCom Inc share’s latest price of $60.02 as on May 5, 2026 at 1:29 am IST, you will get 0.1666 shares of DexCom Inc. Learn more about fractional shares .

What are the returns that DexCom Inc has given to Indian investors in the last 5 years?

DexCom Inc stock has given -32.94% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?